O
Oculis(OCSAW)
ZUG, Switzerland
BiotechnologyFocus: Dexamethasone for Ocular Delivery
Oculis is a life sciences company focused on Dexamethasone for Ocular Delivery.
Ophthalmology
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
1
Pipeline & Clinical Trials
OCS-05 +SoC
Optic NeuritisClinical Trials (1)
NCT04762017OCS-05 in Patients With Optic Neuritis
Phase 2Dexamethasone nanoparticles eye drops
Diabetic Macular EdemaClinical Trials (1)
NCT05343156Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
Phase 2licaminlimab
Dry Eye DiseaseClinical Trials (1)
NCT05896670Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Phase 2Phase 2
Clinical Trials (1)
NCT05608837Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
Phase 2OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL
Inflammation CornealClinical Trials (1)
NCT04130802OCS-01 in Treating Inflammation and Pain in Post-cataract Patients
Phase 2Dexamethasone ophthalmic suspension
Diabetic Macular EdemaClinical Trials (1)
NCT05066997A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
Phase 2/3OCS-01
Inflammation Eye PainClinical Trials (1)
NCT05147233A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Phase 3Dexamethasone Ophthalmic Suspension
Inflammation EyeClinical Trials (1)
NCT06128369Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Phase 3Dexamethasone ophthalmic suspension
Diabetic Macular EdemaClinical Trials (1)
NCT06172257A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
Phase 3Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 9 clinical trials
Open Roles: 1 active job